JN-International Medical Corporation
3 clinical trials · Sponsor
◉ Watch JN-International Medical Corporation
| Record | Firm | Date |
|---|---|---|
| Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study (NCT02500511) | JN-International Medical Corporation | 2015-06-01 |
| Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (NCT01897402) | JN-International Medical Corporation | 2013-07-01 |
| Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis (NCT01482052) | JN-International Medical Corporation | 2011-11-01 |
Track JN-International Medical Corporation automatically
Every clearance here is in the API, with alerts when new ones post.